ISLAMABAD: The Higher Education Commission (HEC) on Friday said it has initiated a project to revamp its degree attestation system by integrating cutting-edge blockchain technology. “This pivotal ...

Binder has introduced the Harsh Environment Connector (HEC) that is engineered for reliable performance in demanding outdoor applications. With robust materials, advanced sealing technology, and a ...

Bain Capital agreed to sell its data centers in China to Shenzhen Dongyangguang Industry Co. in a transaction valued at about $4 billion. Shenzhen Dongyangguang, the parent of Shanghai-listed ...

Marking a historic milestone, the U.S. Coast Guard announced Monday the combined interdiction of more than 76,140 pounds of illicit narcotics. The quantity of drugs offloaded at Port Everglades is the ...

Forbes contributors publish independent expert analyses and insights. Caroline Castrillon covers career, entrepreneurship and women at work. AI is transforming the job application process, with more ...

Revolution Medicines has secured a potential funding infusion of up to $2 billion from Royalty Pharma in return for a slice of the profits if Revolution’s lead cancer drug makes it to market.

I am a proud, unapologetic progressive with a proven track record of action to protect our most vulnerable residents, create better education for our children, and forge pathways to affordable rent ...

Abstract: The world is facing unavoidable disaster challenges, especially floods in Thailand, these inundations have been becoming increasingly difficult to manage each year. Therefore, a preliminary ...

Ras Baraka, the Democratic mayor of Newark, New Jersey, and a candidate for governor, appeared in federal court Thursday for a status conference after being arrested at an ICE facility last week on a ...

Baraka was charged with trespassing, according to court documents. Ras Baraka, the Democratic mayor of Newark, New Jersey, was arrested on Friday while joining members of Congress at an Immigration ...

KRASG12C-targeted therapies like sotorasib and adagrasib have been approved, but resistance challenges persist, necessitating further research into RAS(ON) therapies. Revolution Medicines is ...